Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics
Despite global efforts, it took 7 months between the proclamation of global SARS-CoV-2 pandemic and the first FDA-approved treatment for COVID-19. During this timeframe, clinicians focused their efforts on repurposing drugs, such as hydroxychloroquine (HCQ) or azithromycin (AZM) to treat hospitalize...
Saved in:
Main Authors: | Bérénice Charrez (Author), Verena Charwat (Author), Brian A. Siemons (Author), Ishan Goswami (Author), Courtney Sakolish (Author), Yu-Syuan Luo (Author), Henrik Finsberg (Author), Andrew G. Edwards (Author), Evan W. Miller (Author), Ivan Rusyn (Author), Kevin E. Healy (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vitro safety "clinical trial" of the cardiac liability of drug polytherapy
by: Bérénice Charrez, et al.
Published: (2021) -
Improved Computational Identification of Drug Response Using Optical Measurements of Human Stem Cell Derived Cardiomyocytes in Microphysiological Systems
by: Karoline Horgmo Jæger, et al.
Published: (2020) -
Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction
by: Felipe T. Lee-Montiel, et al.
Published: (2021) -
Identifying Drug Response by Combining Measurements of the Membrane Potential, the Cytosolic Calcium Concentration, and the Extracellular Potential in Microphysiological Systems
by: Karoline Horgmo Jæger, et al.
Published: (2021) -
Microphysiological systems in absorption, distribution, metabolism, and elimination sciences
by: Kirk P. Van Ness, et al.
Published: (2022)